Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities (original) (raw)
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)
Garnet Anderson
Cancer Causes & Control, 2012
View PDFchevron_right
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients
Sls Lorena
Alimentary Pharmacology and Therapeutics, 2006
View PDFchevron_right
Prevalence of Helicobacter pylori Antimicrobial Resistance Among Chilean Patients
Zoltán Berger
Archives of Medical Research, 2021
View PDFchevron_right
Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy
Kadima Teixeira
Alimentary Pharmacology & Therapeutics, 2002
View PDFchevron_right
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial
Garnet Anderson
The Lancet, 2011
View PDFchevron_right
Helicobacter pylori–Related Disease
susan ruffalo
Archives of Internal Medicine, 2000
View PDFchevron_right
Community-based familial study of Helicobacter pylori infection among healthy Japanese Brazilians
Suely Marie
Gastric Cancer, 2006
View PDFchevron_right
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy
menachem moshkowitz
Gut, 1995
View PDFchevron_right
Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report
Colm O'Morain
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
One week triple therapy for Helicobacter pylori Reply
Constanza Lopez
Gut, 1998
View PDFchevron_right
[Helicobacter pylori infection in childhood]
R. Francavilla
Minerva pediatrica
View PDFchevron_right
Seroprevalence and Risk Factors of Helicobacter Pylori Infection Among Children in South-East Nigeria
Olapeju Daniyan
Journal of Gastroenterology and Hepatology Research, 2020
View PDFchevron_right
Epidemiology of Helicobacter Pylori Infection Among the Healthy Population in Lebanon
Khodor Haidar Hassan
World Journal of Pharmacy and Pharmaceutical Sciences, 2017
View PDFchevron_right
Helicobacter pylori: diagnostic dans les années 90
Paola Cognein
Acta Endoscopica, 1995
View PDFchevron_right
Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Ioannis Tsomidis
2024
View PDFchevron_right
Antibiotic resistance of Helicobacter pylori: a cross-sectional study in consecutive patients, and relation to ethnicity
kees fijen
Clinical Microbiology and Infection, 2003
View PDFchevron_right
Natural History of Helicobacter pylori Infection in Childhood: 12‐Year Follow‐up Cohort Study in a Biracial Community
segundo correa moran
Clinical Infectious Diseases, 1999
View PDFchevron_right
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children
Deniz Ertem
European Journal of Gastroenterology & Hepatology, 2014
View PDFchevron_right
Relationship between Helicobacter pylori detection and an increased risk of infection in childhood
Lucas Rasmussen
2012
View PDFchevron_right
Seroprevalence of Helicobacter pylori infection and its related risk factors in symptomatic patients in southern Ethiopia
Demo Yemane
BMC Research Notes, 2014
View PDFchevron_right
Treatment ofHelicobacter pyloriinfection in 2018
Maria Pina Dore
Helicobacter, 2018
View PDFchevron_right
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile
Felipe Valenzuela
World Journal of Gastroenterology, 2007
View PDFchevron_right
Global trends in Helicobacter pylori research from 1991 to 2008 analyzed with the Science Citation Index Expanded
Yuh-shan Ho
European Journal of Gastroenterology & Hepatology, 2011
View PDFchevron_right
Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia
Herry Purbayu
PLOS ONE, 2017
View PDFchevron_right
Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico
Gloria Tilapa
Gut Pathogens, 2017
View PDFchevron_right
Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American CommunitiesH pylori Infection After Eradication Therapy
William Chey
2013
View PDFchevron_right
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication
Guillermo Salazar
Clinical infectious …, 1997
View PDFchevron_right
Factors associated with H pylori epidemiology in symptomatic children in Buenos Aires, Argentina
Marcela Zubillaga
World Journal of Gastroenterology, 2006
View PDFchevron_right
The oral cavity- reservoir of infection with Helicobacter pylori
Klara Dokova
Scripta Scientifica Medicinae Dentalis, 2015
View PDFchevron_right
HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey
Halim Issever
International Journal of Infectious Diseases, 2005
View PDFchevron_right
High prevalence of virulence-associated genotypes in Helicobacter pylori clinical isolates in the Region del Maule, Chile
erik marcelo morales
Scandinavian Journal of Infectious Diseases, 2011
View PDFchevron_right
Unique features and risk factors of Helicobacter pylori infection at the main children’s intermediate school in Rabigh, Saudi Arabia
Hamed Habib
Indian Journal of Gastroenterology, 2014
View PDFchevron_right
Prevalence and Risk Factors for Helicobacter Pylori Infection inGastroduodenal Diseases in Kano, Nigeria
Ahmad Muhammad Bello
African Journal of Medical and Health Sciences, 2018
View PDFchevron_right
Helicobacter Pylori Eradication: Survey conducted by the Colombian Association of Gastroenterology
Luis Sabbagh
2015
View PDFchevron_right